Impaired chromaffin cell excitability and exocytosis in autistic Timothy syndrome TS2-neo mouse rescued by L-type calcium channel blockers.
Action Potentials
Animals
Autistic Disorder
/ genetics
Calcium
/ metabolism
Calcium Channel Blockers
/ pharmacology
Calcium Channels, L-Type
/ genetics
Catecholamines
/ metabolism
Cells, Cultured
Chromaffin Cells
/ drug effects
Exocytosis
Ion Channel Gating
Long QT Syndrome
/ genetics
Male
Mice
Mice, Inbred C57BL
Mitochondria
/ metabolism
Nifedipine
/ pharmacology
Point Mutation
Sodium Channels
/ metabolism
Syndactyly
/ genetics
Cav1.2 calcium channels
Nav sodium channels
burst firing
catecholamine secretion
Journal
The Journal of physiology
ISSN: 1469-7793
Titre abrégé: J Physiol
Pays: England
ID NLM: 0266262
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
21
11
2018
accepted:
19
12
2018
pubmed:
11
1
2019
medline:
10
7
2020
entrez:
11
1
2019
Statut:
ppublish
Résumé
Tymothy syndrome (TS) is a multisystem disorder featuring cardiac arrhythmias, autism and adrenal gland dysfunction that originates from a de novo point mutation in the gene encoding the Cav1.2 (CACNA1C) L-type channel. To study the role of Cav1.2 channel signals in autism, the autistic TS2-neo mouse has been generated bearing the G406R point-mutation associated with TS type-2. Using heterozygous TS2-neo mice, we report that the G406R mutation reduces the rate of inactivation and shifts leftward the activation and inactivation of L-type channels, causing marked increase of resting Ca L-type voltage-gated calcium (Cav1) channels have a key role in long-term synaptic plasticity, sensory transduction, muscle contraction and hormone release. A point mutation in the gene encoding Cav1.2 (CACNA1C) causes Tymothy syndrome (TS), a multisystem disorder featuring cardiac arrhythmias, autism spectrum disorder (ASD) and adrenal gland dysfunction. In the more severe type-2 form (TS2), the missense mutation G406R is on exon 8 coding for the IS6-helix of the Cav1.2 channel. The mutation causes reduced inactivation and induces autism. How this occurs and how Cav1.2 gating-changes alter cell excitability, neuronal firing and hormone release on a molecular basis is still largely unknown. Here, using the TS2-neo mouse model of TS we show that the G406R mutation altered excitability and reduced secretory activity in adrenal chromaffin cells (CCs). Specifically, the TS2 mutation reduced the rate of voltage-dependent inactivation and shifted leftward the activation and steady-state inactivation of L-type channels. This markedly increased the resting 'window' Ca
Identifiants
pubmed: 30629744
doi: 10.1113/JP277487
pmc: PMC6418779
doi:
Substances chimiques
CACNA1C protein, mouse
0
Calcium Channel Blockers
0
Calcium Channels, L-Type
0
Catecholamines
0
Sodium Channels
0
Nifedipine
I9ZF7L6G2L
Calcium
SY7Q814VUP
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1705-1733Subventions
Organisme : Austrian Science Fund FWF
ID : P 27809
Pays : Austria
Informations de copyright
© 2019 University of Torino. The Journal of Physiology © 2019 The Physiological Society.
Références
Physiol Behav. 2000 Mar;68(5):641-9
pubmed: 10764893
Annu Rev Biochem. 1999;68:863-911
pubmed: 10872468
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
pubmed: 12184808
J Neurosci. 2003 Jan 1;23(1):73-83
pubmed: 12514203
Biophys J. 2003 Aug;85(2):1326-37
pubmed: 12885675
Neuron. 2003 Aug 28;39(5):793-806
pubmed: 12948446
Mol Neurobiol. 2004 Feb;29(1):73-96
pubmed: 15034224
Cell. 2004 Oct 1;119(1):19-31
pubmed: 15454078
Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8089-96; discussion 8086-8
pubmed: 15863612
Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3932-7
pubmed: 16537462
Physiol Rev. 2006 Oct;86(4):1093-131
pubmed: 17015485
J Biol Chem. 2006 Dec 22;281(51):39424-36
pubmed: 17038321
Cell Calcium. 2007 Oct-Nov;42(4-5):397-408
pubmed: 17561252
J Pharmacol Exp Ther. 2007 Oct;323(1):39-48
pubmed: 17622574
J Physiol. 2007 Oct 1;584(Pt 1):149-65
pubmed: 17690152
Acta Physiol (Oxf). 2008 Feb;192(2):233-46
pubmed: 18021322
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2157-62
pubmed: 18250309
Neuromolecular Med. 2008;10(2):59-66
pubmed: 18286387
Pflugers Arch. 2009 Mar;457(5):1093-110
pubmed: 18779976
J Physiol. 2009 Feb 1;587(3):551-65
pubmed: 19074970
Nat Neurosci. 2009 Sep;12(9):1093-5
pubmed: 19648911
Br J Pharmacol. 2009 Dec;158(7):1777-86
pubmed: 19888963
J Neurosci. 2010 Jan 13;30(2):491-504
pubmed: 20071512
Neuroscience. 2010 May 19;167(3):786-98
pubmed: 20188150
J Neurosci. 2010 Sep 8;30(36):12157-67
pubmed: 20826678
Trends Neurosci. 2010 Nov;33(11):485-92
pubmed: 20864191
Mol Neurobiol. 2010 Dec;42(3):185-98
pubmed: 21088933
Channels (Austin). 2011 May-Jun;5(3):219-24
pubmed: 21406973
Biochimie. 2011 Dec;93(12):2080-6
pubmed: 21664226
Biomaterials. 2011 Dec;32(34):9040-50
pubmed: 21872323
Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15432-7
pubmed: 21878566
J Neurosci. 2011 Sep 21;31(38):13682-94
pubmed: 21940459
Nat Med. 2011 Nov 27;17(12):1657-62
pubmed: 22120178
Cell Calcium. 2012 Mar-Apr;51(3-4):321-30
pubmed: 22317919
Nature. 2012 Oct 11;490(7419):201-7
pubmed: 23060190
J Neurosci. 2012 Nov 14;32(46):16345-59
pubmed: 23152617
Nat Neurosci. 2013 Feb;16(2):201-9
pubmed: 23313911
Neurotoxicology. 2013 Dec;39:84-94
pubmed: 23999117
N Am J Med Sci (Boston). 2012 Jul 25;5(3):135-140
pubmed: 24371506
Am J Obstet Gynecol. 2014 May;210(5):494-5
pubmed: 24440564
Neuron. 2014 Apr 2;82(1):24-45
pubmed: 24698266
BMC Med Genet. 2014 Apr 29;15:48
pubmed: 24773605
J Gen Physiol. 2014 Oct;144(4):275-95
pubmed: 25267913
J Cell Sci. 2014 Dec 1;127(Pt 23):5105-14
pubmed: 25300794
J Gen Physiol. 2014 Nov;144(5):415-40
pubmed: 25348413
Biochem J. 2015 Feb 1;465(3):405-12
pubmed: 25370603
J Physiol. 2015 Feb 15;593(4):905-27
pubmed: 25620605
Biol Psychiatry. 2015 May 1;77(9):816-22
pubmed: 25620733
Cancer Lett. 2015 May 1;360(2):219-26
pubmed: 25681670
Am J Med Genet A. 2015 Mar;167A(3):629-34
pubmed: 25691416
J Gen Physiol. 1985 May;85(5):621-47
pubmed: 2582076
Neuropharmacology. 2015 Aug;95:252-60
pubmed: 25842242
Curr Mol Pharmacol. 2015;8(2):149-61
pubmed: 25966692
J Physiol. 2015 Nov 15;593(22):4835-53
pubmed: 26282459
Front Cell Neurosci. 2015 Aug 24;9:309
pubmed: 26379493
Cell Calcium. 2015 Dec;58(6):606-16
pubmed: 26459417
Nat Rev Drug Discov. 2016 Jan;15(1):19-34
pubmed: 26542451
Cell Death Differ. 2016 May;23(5):801-13
pubmed: 26586574
Nat Commun. 2016 Jan 29;7:10370
pubmed: 26822303
Science. 2016 Feb 19;351(6275):863-7
pubmed: 26912895
Pathol Int. 2016 Oct;66(10):587-592
pubmed: 27593853
Sci Rep. 2016 Oct 06;6:34528
pubmed: 27708393
J Physiol. 2017 Apr 15;595(8):2587-2609
pubmed: 28026020
Mol Pharmacol. 2017 Apr;91(4):277-286
pubmed: 28119481
Cell Rep. 2017 Feb 14;18(7):1674-1686
pubmed: 28199840
Hum Mol Genet. 2017 Aug 1;26(15):2923-2932
pubmed: 28472301
Mol Pain. 2017 Jan-Dec;13:1744806917710041
pubmed: 28565998
Pflugers Arch. 2018 Jan;470(1):39-52
pubmed: 28776261
Pflugers Arch. 2018 Jan;470(1):7-11
pubmed: 28801866
Pflugers Arch. 2018 Jan;470(1):169-180
pubmed: 28887593
Eur J Neurosci. 2017 Oct;46(8):2416-2425
pubmed: 28921675
Circ Res. 1984 Sep;55(3):336-48
pubmed: 6088117
Proc Natl Acad Sci U S A. 1984 Oct;81(20):6388-92
pubmed: 6093100
Nature. 1983 Apr 28;302(5911):790-4
pubmed: 6302512
J Neurosci. 1995 Sep;15(9):6110-23
pubmed: 7545225
Neuron. 1996 Jun;16(6):1209-20
pubmed: 8663997